Medical oncology

11 – 20 of 609

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1000463?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
…
61
next »

2025
Mark Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH) : a randomised, open-label, phase 2/3 superiority trial
Lewis, David J ; Jerkeman, Mats ^LU ; Sorrell, Lexy ; Wright, David ; Glimelius, Ingrid ; Poulsen, Christian B. ; Pasanen, Annika ; Rawstron, Andrew C. ; Wader, Karin Fahl and Morley, Nick , et al. (2025) In The Lancet
- Contribution to journal › Article
Mark Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review
Ekedahl, Henrik ^LU ; Sigurjonsdottir, Gudbjörg ^LU ; Bergqvist, Viktoria ^LU ; Båtshake, Björn ^LU ; Carneiro, Ana ^LU and Marsal, Jan ^LU (2025) In Acta oncologica (Stockholm, Sweden) 64. p.1365-1370
- Contribution to journal › Scientific review
Mark Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden : LYMPHOMA
Jerkeman, Mats ^LU ; Mellgren, Karin ; Sonnevi, Kristina ; Lisak, Mikael ; Lagerlöf, Ingemar ; Kapas, Balazs ^LU ; Sjölund, Hanna ; Toporski, Jacek ; Hagberg, Hans and Mielke, Stephan , et al. (2025) In Leukemia 39(5). p.1256-1259
- Contribution to journal › Letter
Mark Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor : The AGITG ALT-GIST intergroup randomized phase II trial: Clinical Studies
Yip, Desmond ; Zalcberg, John ; Blay, Jean Yves ; Eriksson, Mikael ^LU ; Espinoza, David ; Price, Timothy ; Marreaud, Sandrine ; Italiano, Antoine ; Steeghs, Neeltje and Boye, Kjetil , et al. (2025) In British Journal of Cancer 132(10). p.897-904
- Contribution to journal › Article
Mark Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies
Harrysson, Sara ; Eloranta, Sandra ; Antonilli, Stefanie ; Runason Simonsen, Mikkel ; Sonnevi, Kristina ; Brown, Peter ; Wahlin, Bjorn E. ; Andersson, Per Ola ; Jørgensen, Judit M. and Jerkeman, Mats ^LU , et al. (2025) In British Journal of Haematology 206(6). p.1834-1839
- Contribution to journal › Letter
Mark Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer : insights from the randomized SweBCG91RT trial
Stenmark Tullberg, Axel ; Thurfjell, Viktoria ; Kovács, Anikó ; Micke, Patrick ; Moustakas, Aristidis ; Killander, Fredrika ^LU ; Niméus, Emma ^LU ; Holmberg, Erik ; Karlsson, Per and Strell, Carina (2025) In Breast Cancer Research and Treatment 212(3). p.499-509
- Contribution to journal › Article
Mark Lymphomas : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Eyre, T. A. ; Cwynarski, K. ; d’Amore, F. ; de Leval, L. ; Dreyling, M. ; Eichenauer, D. A. ; Ferreri, A. J.M. ; Giné, E. ; Kersten, M. J. and Ladetto, M. , et al. (2025) In Annals of Oncology
- Contribution to journal › Article
Mark Inter-reader agreement of quantitative FDG PET/CT biomarkers in lymphoma : a multicentre evaluation of MTV, TLG and Dmax
Trägårdh, Elin ^LU ; Lewold, Malin ^LU ; Urdaneta, Jesus Lopez ; Larsson, Måns ; Enqvist, Olof ^LU ; Barrington, Sally F. ; Jerkeman, Mats ^LU ; Edenbrandt, Lars and Sadik, May (2025) In BMC Medical Imaging 25(1).
- Contribution to journal › Article
Mark Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer : results from a population-based cohort
Sigurjonsdottir, Gudbjörg ^LU ; De Marchi, Tommaso ^LU ; Ehinger, Anna ^LU ; Hartman, Johan ; Ullén, Susann ^LU ; Leandersson, Karin ^LU ; Bosch, Ana ^LU ; Staaf, Johan ^LU ; Killander, Fredrika ^LU and Niméus, Emma ^LU (2025) In Breast Cancer Research and Treatment 210(2). p.271-284
- Contribution to journal › Article
Mark High prevalence of atrial conduction abnormalities in Lewy body disease – a marker of cardiac complications?
Javanshiri, Keivan ^LU ; Siotis, Alexander ^LU ; Heyman, Isak ^LU and Haglund, Mattias ^LU (2025) In GeroScience 47(3). p.3169-3176
- Contribution to journal › Article

« previous
1
2
3
4
5
…
61
next »